The trademark LETRINA was filed by Zwitter Pharmaceuticals Ltd, a corporation established under the laws of the Hellenic Republic (the "Applicant"). The application was published for oppositions on July 30, 2020, and received one opposition filed on October 27, 2020 by Novartis AG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 27, 2020
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).